...
【24h】

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.

机译:肝肾指数计算机化对肝脏脂肪变性的超声定量诊断价值。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Quantification of liver steatosis is clinically relevant in various liver diseases but cannot be done by conventional sonography, which only provides a qualitative assessment with significant observer variability. The aim of this study was to assess sonography as an objective tool for the quantification of liver steatosis. MATERIALS AND METHODS: Files of 111 patients with chronic liver disease who were referred for sonographically guided liver biopsy were collected. A hepatorenal sonographic index was calculated on the basis of the ratio between the echogenicity of the liver and that of the right kidney cortex using histogram echo intensity. Liver steatosis was graded by histology. RESULTS: A significant correlation was found between histologic steatosis and the hepatorenal sonographic index (r = 0.82, p < 0.001). The validity of the hepatorenal sonographic index for the diagnosis of fatty liver was compared with liver biopsies with a steatosis level > 5%. The area under the receiver operating characteristic curve was 99.2% (95% CI, 98-100%). The optimal hepatorenal sonographic index cutoff point for the prediction of steatosis > 5% was 1.49, with sensitivity of 100% and specificity of 91%. The optimal hepatorenal sonographic index cutoff point for the prediction of steatosis >/= 25% was 1.86, with sensitivity of 90% and specificity of 90%. The optimal hepatorenal sonographic index cutoff point for the prediction of steatosis >/= 60% was 2.23, with sensitivity of 90% and specificity of 93%. CONCLUSION: The hepatorenal sonographic index is a sensitive noninvasive method for steatosis quantification. It can diagnose small amounts of liver fat that would be missed by conventional sonography. It is reproducible and operator independent and can serve as an efficient tool to follow patients with steatosis and evaluate the efficacy of new treatment techniques.
机译:目的:对肝脏脂肪变性的量化在各种肝脏疾病中具有临床意义,但不能通过常规超声检查来完成,超声检查只能提供定性评估,且观察者差异很大。这项研究的目的是评估超声检查作为量化肝脂肪变性的客观工具。材料与方法:收集111例经超声引导肝活检的慢性肝病患者的档案。使用直方图回波强度,根据肝脏与右肾皮层的回声性之间的比率,计算肝肾超声指数。肝脂肪变性通过组织学分级。结果:组织学脂肪变性与肝肾超声指标之间存在显着相关性(r = 0.82,p <0.001)。比较肝肾超声指标对脂肪肝的诊断与脂肪变性水平> 5%的肝活检的有效性。接收器工作特性曲线下的面积为99.2%(95%CI,98-100%)。预测脂肪变性> 5%的最佳肝肾超声指数临界点为1.49,敏感性为100%,特异性为91%。预测脂肪变性> / = 25%的最佳肝肾超声指数临界点为1.86,敏感性为90%,特异性为90%。预测脂肪变性> / = 60%的最佳肝肾超声指数临界点为2.23,敏感性为90%,特异性为93%。结论:肝肾超声指数是一种敏感的非侵入性定量脂肪变性的方法。它可以诊断常规超声检查会遗漏的少量肝脂肪。它具有可重现性和独立于操作员的功能,可以作为跟踪脂肪变性患者和评估新治疗技术疗效的有效工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号